We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $32B
1-Year Est. Return 32.86%
This Fund
S&P 500
This Quarter Est. Return
+12.31%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$15.4B
AUM Growth
+$1.27B
Cap. Flow
-$60.1M
Cap. Flow %
-0.39%
Top 10 Hldgs %
26.38%
Holding
2,849
New
208
Increased
1,406
Reduced
723
Closed
51

Top Sells

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$198M
2
CMCSA icon
Comcast
CMCSA
+$32.8M
3
COST icon
Costco
COST
+$21.1M
4
USB icon
US Bancorp
USB
+$21.1M
5
WMT icon
Walmart Inc
WMT
+$15.1M

Sector Composition

Rank Sector Weight
1 Technology 27.33%
2 Financials 12.64%
3 Healthcare 11.6%
4 Consumer Discretionary 9.48%
5 Industrials 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HONE
2601
DELISTED
HarborOne Bancorp
HONE
$267 ﹤0.01%
25
LOGC
2602
DELISTED
ContextLogic
LOGC
$267 ﹤0.01%
47
+12
+34% +$66
SLDP icon
2603
Solid Power
SLDP
$536M
$266 ﹤0.01%
131
+31
+31% +$47
ELVN icon
2604
Enliven Therapeutics
ELVN
$4.35B
$264 ﹤0.01%
15
+6
+67% +$92
EWCZ
2605
DELISTED
European Wax Center
EWCZ
$260 ﹤0.01%
20
+5
+33% +$72
OPAD icon
2606
Offerpad Solutions
OPAD
$22.9M
$259 ﹤0.01%
3
MKTW icon
2607
MarketWise
MKTW
$55.3M
$258 ﹤0.01%
7
URGN icon
2608
UroGen Pharma
URGN
$2.26B
$255 ﹤0.01%
+17
New +$278
ATXS
2609
DELISTED
Astria Therapeutics
ATXS
$253 ﹤0.01%
+18
New +$224
PSTX
2610
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$246 ﹤0.01%
77
+36
+88% +$120
DIBS icon
2611
1stdibs.com
DIBS
$153M
$238 ﹤0.01%
40
PRME icon
2612
Prime Medicine
PRME
$571M
$238 ﹤0.01%
34
+10
+42% +$76
RMAX icon
2613
RE/MAX Holdings
RMAX
$243M
$237 ﹤0.01%
+27
New +$260
PDSB icon
2614
PDS Biotechnology
PDSB
$40.9M
$234 ﹤0.01%
+59
New +$304
WVE icon
2615
Wave Life Sciences
WVE
$1.2B
$234 ﹤0.01%
38
-42
-53% -$210
ARKO icon
2616
ARKO Corp
ARKO
$527M
$228 ﹤0.01%
40
-45
-53% -$328
STRS icon
2617
STRATUS PPTYS INC
STRS
$154M
$228 ﹤0.01%
10
EVLV icon
2618
Evolv Technologies
EVLV
$1.05B
$227 ﹤0.01%
51
+11
+28% +$48
BMEA icon
2619
Biomea Fusion
BMEA
$92.1M
$224 ﹤0.01%
+15
New +$247
VHI icon
2620
Valhi
VHI
$474M
$223 ﹤0.01%
13
SRTA
2621
Strata Critical Medical Inc
SRTA
$525M
$222 ﹤0.01%
78
-6,870
-99% -$21.2K
MACK
2622
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$222 ﹤0.01%
15
UNTY icon
2623
Unity Bancorp
UNTY
$598M
$221 ﹤0.01%
8
ALRS icon
2624
Alerus Financial
ALRS
$827M
$220 ﹤0.01%
10
CGON icon
2625
CG Oncology
CGON
$6.79B
$220 ﹤0.01%
+5
New +$204

Similar funds

Nisa Investment Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Nisa Investment Advisors held 2,849 positions worth $15.4B, up 9% from $14.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nisa Investment Advisors's Q1 2024 filing shows 208 new, 1,406 increased, 723 reduced and 51 closed positions. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 1,031,126 shares worth $52.9M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $198M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • Nisa Investment Advisors's largest Q1 2024 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 1,031,126 shares worth $52.9M.
  • Nisa Investment Advisors added most to Verizon in Q1 2024, an estimated $35.5M increase.
  • Nisa Investment Advisors's biggest Q1 2024 reduction was Comcast, cutting an estimated $32.8M.
  • Nisa Investment Advisors fully exited iShares 20+ Year Treasury Bond ETF in Q1 2024, selling an estimated $198M.
  • Nisa Investment Advisors's ten largest holdings make up 26% of its $15.4B portfolio in Q1 2024.
  • Nisa Investment Advisors opened 208 new positions and closed 51 in Q1 2024.
  • Nisa Investment Advisors's portfolio value rose 9% quarter-over-quarter to $15.4B.

Based on Nisa Investment Advisors's 13F filing for Q1 2024, filed 2 May 2024.